Health authorities in New South Wales issued a warning after a jump in hospitalisations linked to unapproved peptides sold as wellness products.
Recap by typeshit. Post by Facebook on Facebook.
Reuters reports the trend among GLP-1 users is prompting calls for tighter rules on supplements sold alongside the drugs.
A pharmacist account flags two separate Class II recalls involving compounded tirzepatide. Tap through for which products are affected and why.
A University of Iowa chemist found no peptide in a Brooklyn corner-store vial, and another expert flagged at least 13 bacterial colonies that could cause infection.
Cleveland Clinic says early studies give BPC-157 some promise but flags unknown risks, especially when it's bought from gray or black market sellers.
Dr. Noc joined StarTalk to cover GLP-1 drugs, creatine, peptides and looksmaxxing. The full talk is out on YouTube and in podcast apps.
The obesity doctor says commenters once treated her early support for these medications as heresy. She adds that she saw their potential back in 2005.
Loading…